Trials / Completed
CompletedNCT02798159
Safety and Efficacy of TD0025 (Rocket1h) for Treatment of Erectile Dysfunction
A Randomized, Placebo Control, Double-blinded, Double-dummy, Phase 2/3 Combination Study to Evaluate the Safety and Efficacy of TD0025 (Rocket1h) Compared With Sildenafil Citrate for Treatment of Erectile Dysfunction
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 168 (actual)
- Sponsor
- Vietstar Biomedical Research · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to identify the optimal dose(s) of TD0025 for treatment of erectile dysfunction (phase II) and to investigate if treatment of erectile dysfunction with the optimal dose of TD0025 taken as needed over one month is non-inferior than Sildenafil Citrate taken as needed over one month (phase III)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | TD0025 | |
| DRUG | Sildenafil Citrate 50mg |
Timeline
- Start date
- 2016-05-01
- Primary completion
- 2018-03-01
- Completion
- 2018-07-01
- First posted
- 2016-06-14
- Last updated
- 2018-10-11
Locations
1 site across 1 country: Vietnam
Source: ClinicalTrials.gov record NCT02798159. Inclusion in this directory is not an endorsement.